Comparative Pharmacology
Head-to-head clinical analysis: AMPICILLIN SODIUM versus DISPERMOX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMPICILLIN SODIUM versus DISPERMOX.
AMPICILLIN SODIUM vs DISPERMOX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.
1-2 g IV/IM every 4-6 hours for serious infections; maximum 12 g/day.
Adults: 1 g (as amoxicillin 875 mg + clavulanate 125 mg) orally every 12 hours for 7-10 days.
None Documented
None Documented
Terminal elimination half-life ~1 hour in healthy adults; prolonged to 2–5 hours in renal impairment (CrCl <10 mL/min) and up to 7–20 hours in anuria; neonatal half-life 2–4 hours.
Terminal elimination half-life 1.5 hours; prolonged in renal impairment.
Approximately 90% renal excretion via tubular secretion and glomerular filtration; small biliary excretion (<10%); fecal elimination negligible.
Renal excretion 80% as unchanged drug, biliary/fecal 10%.
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic